Author: Multibagger News

Top 6 Wall Street Figures Who Went to Prison: Lessons Learned for Investors Archegos Capital Management founder Sung Kook “Bill” Hwang convicted of fraud and other charges in New York trial Learn from the downfall of Madoff, Bankman-Fried, Belfort, Boesky, Milken, and Rajaratnam In the world of finance, some prominent figures have faced legal troubles for fraudulent activities. From running Ponzi schemes to engaging in insider trading, these individuals have left a mark on Wall Street and the investment world. Here are some key lessons investors can learn from their stories. Bernard Madoff: Known for running the largest-known Ponzi scheme…

Investment Manager’s Insider Report: Prime Minister Keir Starmer Affirms Strong US-UK Relationship with President Biden In a historic meeting at the White House, Britain’s newly elected prime minister, Keir Starmer, emphasized the enduring strength of the special relationship between Britain and the United States. President Joe Biden echoed this sentiment, highlighting the importance of the partnership in navigating global challenges. As an investment manager, staying informed about geopolitical developments like this is crucial for making sound investment decisions. The US-UK relationship has significant implications for global markets, with potential impacts on trade agreements, economic policies, and international security. For investors,…

AK Jensen Investment Management Ltd Increases Stake in ASP Isotopes Inc. by $515,000 – Latest Investment News 2024 In a recent spree of transactions, AK Jensen Investment Management Ltd has significantly increased its stake in ASP Isotopes Inc. (OTC:ASPI), a company in the miscellaneous chemical products sector. Over three days, the investment firm bought shares totaling approximately $515,000, with prices ranging from $3.048 to $3.3991 per share. AK Jensen’s buying spree started on July 8, 2024, with the acquisition of 70,000 shares at an average price of $3.048. The firm continued accumulating the following day, adding another 30,000 shares at…

Honeywell Prevails in Landmark Diversity Training Case: What It Means for Employers and Employees By Jonathan Stempel (Multibagger) – In a significant ruling, the 7th U.S. Circuit Court of Appeals in Chicago determined that Honeywell did not breach workplace anti-discrimination laws by terminating a white engineer, Charles Vavra, who refused to partake in mandatory diversity, equity, and inclusion (DEI) training initiated following the Black Lives Matter movement. The court’s 3-0 decision confirmed that Vavra’s claims lacked merit, as there was no substantiated evidence that Honeywell acted in retaliation when he objected to a video designed to address unconscious bias in…

Market Analysis: U.S. Inflation Report to Test Markets Amid Rate Cut Expectations As the markets brace for Thursday’s U.S. inflation report, the possibility of the first Federal Reserve rate cut of this cycle in September looms large. Consensus suggests that the consumer price report for June may show a slight moderation in the annual change to 3.1% from 3.3% the previous month. Currently, Fed funds futures indicate a 70% chance of an easing at the September meeting, according to CME FedWatch. However, rate-cut expectations have been volatile this year, and any unexpected spike in inflation could disrupt projections and impact…

US to Deploy Long-Range Fire Capabilities in Germany by 2026 In a groundbreaking move to showcase its dedication to NATO and European defense, the United States and Germany have announced plans to deploy long-range fire capabilities in Germany by 2026. This strategic move involves the stationing of SM-6, Tomahawk cruise missiles, and cutting-edge hypersonic weapons with extended ranges in Europe. Historically, ground-based missiles with ranges exceeding 500 kilometers were prohibited under the Intermediate-Range Nuclear Forces Treaty signed by Mikhail Gorbachev and Ronald Reagan in 1987. This treaty marked a significant milestone in nuclear disarmament by eliminating an entire category of…

Title: Bitcoin Price Analysis: Will the Recent Decline Continue or is a Rebound on the Horizon? As the world’s best investment manager and financial market journalist, I am here to break down the recent decline in Bitcoin price and its potential implications for your finances. Bitcoin has plummeted by 17% in the past month, hitting its lowest level since February 2024. Despite a minor uptick in the last five days, the cryptocurrency is struggling to recover. Currently trading around $57,800, Bitcoin has dipped below the critical $60,000 mark. Two primary factors have contributed to this decline. The first is the…

Insider Trading Alert: Morphic Holding Inc CFO Sells $2.45M Worth of Shares Amid Acquisition News In a recent development, Morphic Holding, Inc.’s CFO and COO, Marc Schegerin, has sold a substantial number of shares in the company. The transactions, totaling over $2.45 million, took place on July 8, 2024. This move coincides with Schegerin’s acquisition of the same number of shares through options exercise at a lower price. This insider trading activity has caught the attention of investors and analysts, especially in light of Morphic Holding Inc’s planned acquisition by Eli Lilly and Company. Following the acquisition news, financial firms…

Gold Demand Softens in Q2 But Analysts Expect Record Prices in 2024 Citi analysts predict that physical gold demand may have softened in the second quarter compared to the first, but it is still growing positively overall. They anticipate spot trading prices to reach a record average range of $2,400-$2,600 per ounce in the second half of 2024 as financial investors catch up. Non-monetary gold imports into China decreased in Q2, but Citi projects a record onshore bullion import of 1,750 tons in 2024, marking an 18% year-on-year increase. Chinese retail gold imports are expected to represent 47% of world…

Bernie Sanders Challenges Novo Nordisk to Cut U.S. Prices of Ozempic and Wegovy: A Potential Game-Changer for American Consumers By Ahmed Aboulenein WASHINGTON (Multibagger) – Senator Bernie Sanders is turning up the heat on Novo Nordisk (NYSE: NVO), urging the pharmaceutical giant to lower the U.S. prices of its high-demand weight loss drugs, Ozempic and Wegovy. By leveraging public scrutiny, Sanders aims to pressure Novo Nordisk into aligning its U.S. prices with those in other countries. A Senate Showdown: Novo Nordisk CEO to Testify Lars Jorgensen, CEO of Novo Nordisk, is slated to testify before the Senate Committee on Health,…